Yonsei Med J.
2009 Jun;50(3):331-334. 10.3349/ymj.2009.50.3.331.
Genetic and Epigenetic Marker-Based DNA Test of Stool Is a Promising Approach for Colorectal Cancer Screening
- Affiliations
-
- 1Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea. sungwhan@genomictree.com
- 2Genomictree, Inc., Daejeon, Korea.
- 3Department of General Surgery, Yonsei University College of Medicine, Seoul, Korea.
- 4Yonsei Cancer Center, Yonsei Cancer Research Institute, Yonsei University College of Medicine, Seoul, Korea.
- KMID: 1758558
- DOI: http://doi.org/10.3349/ymj.2009.50.3.331
Abstract
- Colorectal cancer (CRC) is one of the most common malignancies and leading cause of cancer-related deaths in the world. However, it may be treated effectively by surgical removal of the cancerous tissue if detected at early stages. Conventional tools for screening CRC are either invasive or inaccurate. Therefore, there is an urgent need to develop a reliable screening tools for CRC to significantly reduce its morbidity. In this regard, a novel DNA markers-based detection in stool is emerging as a promising approach.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Stool DNA Testing for Colorectal Cancer: Development and Advances
- Stool Based DNA Biomarkers for Colorectal Cancer Diagnosis
- Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities
- Recent Advances in Noninvasive Tests for Colorectal Cancer Screening
- Genetic and epigenetic alterations of colorectal cancer
